China’s Pharmaceutical Innovation Hub: A Rising Global Player
China’s pharmaceutical industry is undergoing a transformation, moving away from being known as a copycat drug maker to becoming a hub for innovation in the field. According to a global consultancy, China’s infrastructure and research and development capabilities are now on par with major global pharmaceutical companies.
US-based SAI MedPartners and its unit Idea Pharma recently introduced the China Pharmaceutical Innovation and Invention Index (CPIII). This index aims to highlight Chinese drug makers who are transitioning from generics to true innovation. The consultancy released the CPIII on December 7, marking the first time a standalone ranking for Chinese pharmaceutical innovation has been published after 14 years of a global pharmaceutical innovation index.
Jacqueline Poot, the president of Idea Pharma’s strategic consulting and analytics business unit in London, emphasized that Chinese companies are becoming more efficient in developing medicines. For instance, while the average global cost to bring a new medicine to market is around US$5 billion, companies like Hengrui can do so for close to US$1 billion.
The index evaluated 30 mainland Chinese companies, with Jiangsu Hengrui Pharmaceuticals claiming the top spot, followed by BeOne. Hengrui excels in solid tumor treatments, while BeOne has made a mark with its BTK inhibitor zanubrutinib and PD-1 inhibitor tislelizumab for cancer treatments.
The index is divided into two sub-indices: the innovation index, which measures how effectively companies translate inventions into clinical and commercial value, and the invention index, which tracks the creation of novel drugs and technologies.
Celia Deng, the president for Asia at SAI MedPartners, noted that China is evolving into a global pharmaceutical innovation hub with a focus on areas like antibody-drug conjugates and CAR-T therapy. CAR-T is a personalized cancer treatment that reprograms a patient’s immune cells to target and destroy cancer cells effectively.
Government policy support in China is accelerating the development of innovative drugs, from regulatory approval to reimbursement and uptake in hospitals. Commercial insurers have also been involved in national drug reimbursement talks for the first time this year.
Other players in the innovation index include Sino Biopharmaceutical, Innovent Biologics, and Hansoh Pharmaceutical Group. Rising stars in pharmaceutical innovation this year include Alphamab Oncology, DualityBio, Harbour BioMed, Minghui Pharmaceutical, and Virogin Biotech.
While Chinese pharmaceutical companies have yet to achieve the global recognition of tech giants like Huawei and BYD, there is significant progress in terms of licensing, co-development, and international recognition. The industry is witnessing a surge in innovation, positioning China as a key player in the global pharmaceutical landscape. The Impact of Social Media on Mental Health
In today’s digital age, social media has become an integral part of our daily lives. From connecting with friends and family to staying updated on current events, social media platforms like Facebook, Instagram, and Twitter have revolutionized the way we communicate and interact with others. However, along with its many benefits, social media also has a dark side that is often overlooked – its impact on mental health.
Research has shown that excessive use of social media can lead to negative mental health outcomes, including increased feelings of depression, anxiety, and loneliness. The constant comparison to others, the pressure to present a perfect image online, and the fear of missing out on social events can all contribute to feelings of inadequacy and low self-esteem.
Moreover, social media has been linked to poor sleep quality, as many individuals spend hours scrolling through their feeds late into the night. This can disrupt the body’s natural sleep-wake cycle, leading to fatigue, irritability, and difficulty concentrating during the day.
Another concerning aspect of social media is cyberbullying. With the anonymity that the internet provides, individuals may feel emboldened to engage in hurtful or malicious behavior towards others. Cyberbullying can have devastating effects on a person’s mental health, leading to feelings of shame, worthlessness, and even thoughts of self-harm.
Despite these negative consequences, it is important to recognize that social media is not inherently bad. In fact, it can be a valuable tool for connecting with others, sharing experiences, and finding support. The key is to use social media mindfully and in moderation.
Here are some tips for maintaining good mental health while using social media:
Set boundaries: Limit the amount of time you spend on social media each day and establish designated “screen-free” times, such as during meals or before bed.
Practice self-care: Take breaks from social media when you feel overwhelmed or anxious. Engage in activities that promote relaxation and self-care, such as exercise, meditation, or spending time outdoors.
Be mindful of your online interactions: Be kind and respectful towards others online and avoid engaging in negative or hurtful conversations. If you experience cyberbullying, report the behavior and seek support from a trusted friend or mental health professional.
Seek help when needed: If you are struggling with your mental health, don’t hesitate to reach out for help. Talk to a therapist or counselor who can provide guidance and support.
In conclusion, social media can have a significant impact on mental health, both positive and negative. By being mindful of your online behavior and setting boundaries for yourself, you can use social media in a way that enhances your well-being rather than detracts from it. Remember, it’s important to prioritize your mental health and take care of yourself both online and offline.
